BACKGROUND: The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) will soon replace the DSM-IV, which has existed for nearly two decades. The changes in diagnostic criteria have important implications for research and for the clinical care of individuals with Substance Use Disorders (SUDs). METHODS: We used the Semi-Structured Assessment for Drug Dependence and Alcoholism to evaluate the lifetime presence of DSM-IV abuse and dependence diagnoses and DSM-5 mild, moderate, or severe SUDs for alcohol, cocaine, opioids, and cannabis in a sample of 7,543 individuals recruited to participate in genetic studies of substance dependence. RESULTS: Switches between diagnostic systems consistently resulted in a modestly greater prevalence for DSM-5 SUDs, based largely on the assignment of DSM-5 diagnoses to DSM-IV "diagnostic orphans" (i.e., individuals meeting one or two criteria for dependence and none for abuse, and thus not receiving a DSM-IV SUD diagnosis). The vast majority of these diagnostic switches were attributable to the requirement that only two of 11 criteria be met for a DSM-5 SUD diagnosis. We found evidence to support the omission from DSM-5 of the legal criterion due to its limited diagnostic utility. The addition of craving as a criterion in DSM-5 did not substantially affect the likelihood of an SUD diagnosis. CONCLUSION: The greatest advantage of DSM-5 for the diagnosis of SUDs appears to be its ability to capture diagnostic orphans. In this sample, changes reflected in DSM-5 had a minimal impact on the prevalence of SUD diagnoses.
BACKGROUND: The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) will soon replace the DSM-IV, which has existed for nearly two decades. The changes in diagnostic criteria have important implications for research and for the clinical care of individuals with Substance Use Disorders (SUDs). METHODS: We used the Semi-Structured Assessment for Drug Dependence and Alcoholism to evaluate the lifetime presence of DSM-IV abuse and dependence diagnoses and DSM-5 mild, moderate, or severe SUDs for alcohol, cocaine, opioids, and cannabis in a sample of 7,543 individuals recruited to participate in genetic studies of substance dependence. RESULTS: Switches between diagnostic systems consistently resulted in a modestly greater prevalence for DSM-5 SUDs, based largely on the assignment of DSM-5 diagnoses to DSM-IV "diagnostic orphans" (i.e., individuals meeting one or two criteria for dependence and none for abuse, and thus not receiving a DSM-IV SUD diagnosis). The vast majority of these diagnostic switches were attributable to the requirement that only two of 11 criteria be met for a DSM-5 SUD diagnosis. We found evidence to support the omission from DSM-5 of the legal criterion due to its limited diagnostic utility. The addition of craving as a criterion in DSM-5 did not substantially affect the likelihood of an SUD diagnosis. CONCLUSION: The greatest advantage of DSM-5 for the diagnosis of SUDs appears to be its ability to capture diagnostic orphans. In this sample, changes reflected in DSM-5 had a minimal impact on the prevalence of SUD diagnoses.
Authors: Amira Pierucci-Lagha; Joel Gelernter; Richard Feinn; Joseph F Cubells; Deborah Pearson; Alisha Pollastri; Lindsay Farrer; Henry R Kranzler Journal: Drug Alcohol Depend Date: 2005-12-12 Impact factor: 4.492
Authors: Amira Pierucci-Lagha; Joel Gelernter; Grace Chan; Albert Arias; Joseph F Cubells; Lindsay Farrer; Henry R Kranzler Journal: Drug Alcohol Depend Date: 2007-06-27 Impact factor: 4.492
Authors: Risë B Goldstein; S Patricia Chou; Sharon M Smith; Jeesun Jung; Haitao Zhang; Tulshi D Saha; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant Journal: J Stud Alcohol Drugs Date: 2015-05 Impact factor: 2.582
Authors: João Mauricio Castaldelli-Maia; Camila M Silveira; Erica R Siu; Yuan-Pang Wang; Igor A Milhorança; Clóvis Alexandrino-Silva; Guilherme Borges; Maria C Viana; Arthur G Andrade; Laura H Andrade; Silvia S Martins Journal: Drug Alcohol Depend Date: 2014-01-03 Impact factor: 4.492
Authors: Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Arethusa Kirk; Kevin E O'Grady; Robert P Schwartz Journal: Drug Alcohol Depend Date: 2014-04-13 Impact factor: 4.492
Authors: Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant Journal: Am J Psychiatry Date: 2013-08 Impact factor: 18.112
Authors: Ryan C Shorey; Anne E Dawson; Ellen Haynes; Catherine Strauss; JoAnna Elmquist; Scott Anderson; Gregory L Stuart Journal: J Psychoactive Drugs Date: 2016-09-14
Authors: June H Kim; Silvia S Martins; Dvora Shmulewitz; Julian Santaella; Melanie M Wall; Katherine M Keyes; Nicholas R Eaton; Robert Krueger; Bridget F Grant; Deborah S Hasin Journal: Alcohol Clin Exp Res Date: 2014-06-24 Impact factor: 3.455
Authors: Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin Journal: Addict Behav Date: 2016-08-30 Impact factor: 3.913